Sign in:
Email
 Password  save:
  
 Company Reports 
 

   
My Recent Searches
  Help
 
   
 
 
   Get Roster for :  
An2 Therapeutics Ord Shs (ANTX)  
$1.06 0.15 (12.4%) as of 4:30 Fri 5/30


Download
   
  Company Roster

Total Insiders  : 17  
Total Direct Shares :
2,951,037
Total Indirect Shares :
11,380,685
 
% Held by Insiders:
9.92%
 
7 other people own 
 $177,478 Prior Stephen David
 $64,992 Day Lucy
 $83,920 Chanda Sanjay
 $84,878 Zakrzewski Joseph S
 $154,270 Eizen Joshua M
 $185,682 Easom Eric
 $261,163 Adjuvant Capital Manageme...
 $2,115,715  
 
Filer's Name Relation Direct Date   Direct Shares Indirect Date Indirect Shares
   Fitzpatrick Margaret M 2025-05-28 8,610 2025-05-28 0
   Martin Patricia A. 2025-04-10 6,231 2024-12-19 0
   Zakrzewski Joseph S 2025-04-10 145,538 2025-04-10 405,880
   Aziz Kabeer 2025-04-10 18,677 2025-04-10 2,373,500
   Marks Gilbert Lynn 2025-04-10 41,507 0
   Eizen Joshua M 2025-02-26 175,172 2024-03-15 0
   Easom Eric 2025-02-26 246,380 2025-02-26 1,259,882
   Chanda Sanjay 2025-02-26 80,074 2024-03-15 0
   Day Lucy 2025-02-26 79,170 2024-03-15 0
   Prior Stephen David 2025-02-26 61,313 2024-11-04 0
   Readnour Robin Shane 2024-12-19 9,077 2024-12-19 1,234,861
   Leonard Braden Michael 2024-08-14 0 2025-05-30 3,217,432
   Eckburg Paul 2024-03-15 51,416 0
   Krause Kevin Michael 2024-03-15 31,914 2024-01-02 0
   Adjuvant Capital Management, Llc 2024-01-16 1,995,958 2024-01-16 377,542
   Shah Rajeev M. 10% Owner 2022-03-29 0 2024-08-09 300,853
   Adjuvant Global Health Technology Fund De, L.p. 10% Owner 2022-03-29 0 2022-03-29 2,210,735
17 Records found